AtaiBeckley Stock Surges After Acquisition Agreement with Eli Lilly

Shares of AtaiBeckley surged after the mental health-focused biotech company agreed to be acquired by pharmaceutical giant Eli Lilly. The deal includes a $6.75 per share cash offer and potential milestone payments, valuing the acquisition at up to $3.8 billion if all conditions are met.

By Joe Tenebruso, The Motley Fool Fri, July 17, 2026 at 1:32 AM GMT+3 3 min read · Yahoo Finance · July 16, 2026, 22:32 UTC

AtaiBeckley Stock Surges After Acquisition Agreement with Eli Lilly

Tickers: $ATAI $LLY

Topics: Biotechnology Mergers & Acquisitions Pharmaceuticals

Read the full article at Yahoo Finance

More World news

Nvidia CEO Jensen Huang Resigns Amid Investigation and Personal Allegations Motley Fool · November 12, 2026, 17:20 UTC
Argus Research Upgrades Republic Services to Buy Seeking Alpha · November 12, 2026, 17:16 UTC
Moderna Shares Decline Following Analyst Day Projections and Future Cost Concerns Motley Fool · November 12, 2026, 17:13 UTC
United Airlines Restricts AI Agent Access to Booking Systems Due to Cybersecurity and Regulatory Concerns TechCrunch · November 12, 2026, 17:17 UTC
Global Payments Shares Drop 12% Following Reports Private Equity Firms Abandoned Takeover Bid Seeking Alpha · November 12, 2026, 17:14 UTC
Nvidia Appoints Colette Kress as Interim CEO Following Jensen Huang's Resignation CNBC · November 12, 2026, 16:59 UTC
Brookfield Corporation Reports Strong Third Quarter Earnings Growth and Increased Share Buybacks Motley Fool · November 12, 2026, 17:08 UTC
Franco-Nevada Reports Q3 2026 Revenue Growth Driven by Higher Gold and Oil Prices Motley Fool · November 12, 2026, 17:10 UTC
Stratasys Reports Q3 2026 Revenue Growth Driven by Aerospace and Defense Demand Motley Fool · November 12, 2026, 17:11 UTC
Jim Cramer Advises Profit-Taking Following Jensen Huang's Resignation at Nvidia CNBC · November 12, 2026, 16:59 UTC